Research Portal

Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC

Research output: Contribution to journal › Article › peer-review

  • N.S. Stuart
  • G. von Minckwitz
  • I. Chernozemsky
  • L. Sirakova
  • P. Chilingirov
  • R. Souchon
  • N. Marschner
  • U. Kleeberg
  • C. Tsekov
  • D. Fritze
  • C.F. Thomssen
  • N. Stuart
  • J.B. Vermorken
  • S. Loibl
  • K.H. Merkle
  • M. Kaufmann
Original languageEnglish
Pages (from-to)871-877
JournalAnti-Cancer Drugs
Volume16
Issue number8
Publication statusPublished - 1 Sept 2005
View graph of relations